Tesla rejected at 200-day MA, lags Magnificent 7
Tesla was rejected at its 200‑day moving average, lagging the Magnificent 7 and down about 4% since the April 8 US‑Iran ceasefire and 14.1% year‑to‑date.
Tesla shares were rejected at the 200‑day moving average after a rally in early April, leaving trading stalled and the stock trailing its large-cap peers. As of April 21, 2026, Tesla was down about 4% since the April 8 US‑Iran ceasefire and 14.1% year‑to‑date.
Market data show the Magnificent 7 led the post‑ceasefire rebound from a late‑February baseline to April 21, with Amazon up roughly 19%, Nvidia 12.8% and Microsoft about 8% over that span. Over the same period, Tesla fell about 4% and remained the worst performer among the group year‑to‑date.
Price action since Tesla’s December 18, 2024 high of $488.54 has formed a potential double‑top pattern. The stock’s recent bounce from an April low stalled at the 200‑day moving average. Daily charts show a key resistance at $417.40 and an intermediate support at $363.80.
If $363.80 is breached, additional support levels appear at $337.25 and $328.20, which correspond to the 61.8% Fibonacci retracement of the prior up move. Lower technical levels are near $300.05 and $288.80, which align with the 76.4% retracement of the same move.
Momentum indicators show Tesla’s volatility‑adjusted relative strength versus the S&P 500 has been below zero since late January 2026. The daily relative strength index stalled at a descending resistance near 60 during the recent recovery attempt.
Tesla is scheduled to report first‑quarter 2026 results after the close on April 22, 2026. Consensus estimates project earnings per share of about $0.35, up from $0.27 in the same quarter a year earlier. A daily close above $417.40 would clear the identified resistance and leave next resistances around $437.40, $450.20 and the all‑time high near $498.83.
The content on The Coinomist is for informational purposes only and should not be interpreted as financial advice. While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any content. Neither we accept liability for any errors or omissions in the information provided or for any financial losses incurred as a result of relying on this information. Actions based on this content are at your own risk. Always do your own research and consult a professional. See our Terms, Privacy Policy, and Disclaimers for more details.








